Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
BACKGROUND:WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. We undertook a secondary analysis of data from 30 surveys in low- and middle-i...
Main Authors: | Margaret Ewen, Marjolein Zweekhorst, Barbara Regeer, Richard Laing |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5295694?pdf=render |
Similar Items
-
The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries
by: Shanti Mendis, et al.
Published: (2007-04-01) -
Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania
by: M. Ewen, et al.
Published: (2017-12-01) -
Availability, price and affordability of cardiovascular medicines: <it>A comparison across 36 countries using WHO/HAI data</it>
by: Cameron Alexandra, et al.
Published: (2010-06-01) -
Availability, prices and affordability of essential medicines in Haiti
by: Harinder Singh Chahal, et al.
Published: (2013-12-01) -
Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal
by: Saval Khanal PhD, et al.
Published: (2019-12-01)